ALABAstera Labs, Inc.

Company: Astera Labs, Inc. (NASDAQ: ALAB) Form Type: 10-Q Filed: 2026-11-04 Current Price: $185.05 | Today's Change: -17.12%

---

What Happened

Astera Labs filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, disclosing results for its third fiscal quarter of 2026. Revenue came in at $581.9 million, with net income of $174.2 million and operating income of $106.5 million. Diluted earnings per share were $0.97, while basic EPS reached $1.05. Despite what are, in absolute terms, substantial reported profits, shares are trading sharply lower on the day — down more than 17% — suggesting the market's reaction is being driven by factors beyond the headline figures alone, such as forward guidance, margin mix, or competitive commentary that may appear elsewhere in the full filing.

---

Why It Matters

For investors following Astera Labs, the Q3 FY2026 numbers represent a significant milestone: the company is generating nearly $582 million in quarterly revenue and has crossed into consistent profitability, with both operating and net income firmly positive. The operating-to-net income gap — $106.5M operating vs. $174.2M net — is notable, implying meaningful below-the-line contributions (such as interest income or tax benefits) are boosting the bottom line beyond the core operating result. That dynamic is worth scrutiny, as it may not be fully repeatable.

The sharp stock decline of over 17% on the day of the report is a material market event in its own right. It signals that investor expectations — whether for revenue growth trajectory, gross margin, or future-quarter guidance — were not met by this filing or by any accompanying management commentary. When a stock falls this aggressively on earnings, it typically reflects a reset of near-term growth assumptions.

---

Analysis

Astera Labs has demonstrated impressive scale in Q3 FY2026, with nearly $582M in revenue and a net income margin of roughly 30% — metrics that reflect a company that has grown rapidly in the AI connectivity semiconductor space. Our existing coverage, initiated in September 2026, reflects the strong structural position we identified for the company in that environment.

However, the market's reaction today tells a different story about expectations versus outcomes. At a share price that — even after today's decline to $185 — implies a premium valuation relative to most semiconductor peers, investors were clearly pricing in results or guidance that this 10-Q either did not deliver or walked back. The divergence between operating income ($106.5M) and net income ($174.2M) warrants a closer read of the full filing for one-time items or non-operating gains that inflated the bottom line.

Key things to watch as more of the filing's details become available:

• Gross margin trends: Did product mix shift toward lower-margin offerings?
• Forward guidance: Was the Q4 FY2026 outlook revised downward?
• Customer concentration: Any change in the reliance on hyperscaler customers?
• Below-the-line items: What drove the ~$68M gap between operating and net income?

The 10-Q was filed on November 4, 2026, and the full document will contain management's discussion and analysis as well as any risk factor updates that could clarify the market's sharp negative reaction.

---

Disclaimer

This report is a news and informational summary based solely on data extracted from Astera Labs' publicly filed SEC documents and is provided for informational purposes only. It does not constitute investment advice, an offer to buy or sell securities, or a recommendation of any kind. Readers should conduct their own due diligence and consult a qualified financial professional before making any investment decisions. This report carries no rating and no price target.

Existing Coverage

StockWatch has full coverage on ALAB, published 2026-09-04. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-11-04. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000045/alab-20260930.htm